BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37968262)

  • 1. mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions.
    Cosialls E; Pacreau E; Duruel C; Ceccacci S; Elhage R; Desterke C; Roger K; Guerrera C; Ducloux R; Souquere S; Pierron G; Nemazanyy I; Kelly M; Dalmas E; Chang Y; Goffin V; Mehrpour M; Hamaï A
    Cell Death Dis; 2023 Nov; 14(11):744. PubMed ID: 37968262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinomycin-Loaded Gold Nanoparticles for Treating Cancer Stem Cells by Ferroptosis-Induced Cell Death.
    Zhao Y; Zhao W; Lim YC; Liu T
    Mol Pharm; 2019 Jun; 16(6):2532-2539. PubMed ID: 31009228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salinomycin Derivatives Kill Breast Cancer Stem Cells by Lysosomal Iron Targeting.
    Versini A; Colombeau L; Hienzsch A; Gaillet C; Retailleau P; Debieu S; Müller S; Cañeque T; Rodriguez R
    Chemistry; 2020 Jun; 26(33):7416-7424. PubMed ID: 32083773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.
    Baba Y; Higa JK; Shimada BK; Horiuchi KM; Suhara T; Kobayashi M; Woo JD; Aoyagi H; Marh KS; Kitaoka H; Matsui T
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H659-H668. PubMed ID: 29127238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
    Yi J; Zhu J; Wu J; Thompson CB; Jiang X
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance.
    Yue W; Hamaï A; Tonelli G; Bauvy C; Nicolas V; Tharinger H; Codogno P; Mehrpour M
    Autophagy; 2013 May; 9(5):714-29. PubMed ID: 23519090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.
    Yang Y; Lu Y; Zhang C; Guo Q; Zhang W; Wang T; Xia Z; Liu J; Cheng X; Xi T; Jiang F; Zheng L
    Cell Mol Life Sci; 2022 Jun; 79(7):360. PubMed ID: 35690642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salinomycin kills cancer stem cells by sequestering iron in lysosomes.
    Mai TT; Hamaï A; Hienzsch A; Cañeque T; Müller S; Wicinski J; Cabaud O; Leroy C; David A; Acevedo V; Ryo A; Ginestier C; Birnbaum D; Charafe-Jauffret E; Codogno P; Mehrpour M; Rodriguez R
    Nat Chem; 2017 Oct; 9(10):1025-1033. PubMed ID: 28937680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.
    Lai Y; Yu X; Lin X; He S
    Int J Mol Med; 2016 Feb; 37(2):369-77. PubMed ID: 26707081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
    Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
    Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 differentially regulates autophagy in stem-like versus differentiated cancer cells.
    Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Hanes MR; Murphy PJ; Margam NN; Parmar HB; Giacomantonio CA; Duncan R; Lee PWK; Gujar S
    Autophagy; 2019 Apr; 15(4):686-706. PubMed ID: 30444165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It.
    Cosialls E; El Hage R; Dos Santos L; Gong C; Mehrpour M; Hamaï A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lysosomal TRPML1 channel eliminates breast cancer stem cells by triggering ferroptosis.
    Fan C; Wu H; Du X; Li C; Zeng W; Qu L; Cang C
    Cell Death Discov; 2024 May; 10(1):256. PubMed ID: 38802335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
    Yao HJ; Zhang YG; Sun L; Liu Y
    Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between telomerase and mTOR pathway in cancer stem cells.
    Dogan F; Biray Avci C
    Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells.
    Daimon T; Bhattacharya A; Wang K; Haratake N; Nakashoji A; Ozawa H; Morimoto Y; Yamashita N; Kosaka T; Oya M; Kufe DW
    Cell Death Discov; 2024 Jan; 10(1):9. PubMed ID: 38182558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells.
    Zhang X; Ai Z; Zhang Z; Dong R; Wang L; Jin S; Wei H
    DNA Cell Biol; 2022 Aug; 41(8):705-715. PubMed ID: 35687364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High collagen density augments mTOR-dependent cancer stem cells in ERα+ mammary carcinomas, and increases mTOR-independent lung metastases.
    Shea MP; O'Leary KA; Wegner KA; Vezina CM; Schuler LA
    Cancer Lett; 2018 Oct; 433():1-9. PubMed ID: 29935374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.